Dr. Daniele Massera, MD

Dr. Massera practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Massera's NPI, 1538457049, was assigned on July 18, 2011. Dr. Massera holds New York license 278611.

Dr. Massera's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Massera's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Massera is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Massera to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Massera practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Massera's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Massera is licensed in New York.

CMS data shows 1,995 Medicare services from Dr. Massera across 19 procedure codes in 2024, for 406 Medicare patients. Medicare paid $119,684 for them.

CMS counts 406 Medicare patients who saw Dr. Massera in 2024. The largest group is 65 to 74, with 184 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Massera's median patient age at 62, with 42% women.

In 2024, Dr. Massera wrote 873 Medicare Part D claims for 208 patients. 73% of them were for generic drugs. CMS names the drug for 752 of them, across 17 drugs with 11 or more claims each, at $1,081,804 in total drug cost. In 2023, CMS named 573 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Massera for performance year 2024, reported as part of a group. Dr. Massera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Massera as offering telehealth.

Dmand AI links 64 papers to Dr. Massera, published from 2010 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Cardiomyopathy, Hypertrophic, Aortic Valve and Aortic Valve Stenosis. Dr. Massera has published most often in Heart. Dr. Massera's most frequent co-authors are Mark V. Sherrid, MD, Jorge R. Kizer, MD and Daniel George Swistel, MD.

CMS Open Payments shows 132 general payments to Dr. Massera from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Sanofi and Genzyme US Companies paid the most, $95,335.